Form 4: Camden National Corp Director Marie J. McCarthy Increases Stake Through Equity Grant

Camden National Corp Director Marie J. McCarthy was granted 890 shares of common stock under the company's equity compensation program, increasing her total beneficial ownership to 14,649.874 shares.

Summary

• Director Marie J. McCarthy acquired 890 shares of Camden National Corp (CAC) common stock.
• The shares were granted on May 30, 2025, under the Independent Directors' Equity Compensation Program, which is a component of the 2022 Equity and Incentive Plan.
• The acquisition price for these shares was $0, as they were part of an equity compensation grant and vested immediately on the date of the grant.
• Following this transaction, Ms. McCarthy's total beneficial ownership in Camden National Corp stands at 14,649.874 shares.
• This total beneficial ownership includes an additional 145.661 shares acquired since the last filing through participation in the Company's dividend reinvestment program.

Sentiment

Score: 7

Explanation: The filing indicates a routine equity grant to an independent director, increasing their beneficial ownership and aligning their interests with shareholders, which is generally viewed positively as a standard corporate governance practice.

Positives

• Director Marie J. McCarthy's beneficial ownership in Camden National Corp increased to 14,649.874 shares, which generally aligns her interests more closely with those of common shareholders.
• The grant of 890 shares under the Independent Directors' Equity Compensation Program demonstrates the company's established framework for incentivizing and compensating its board members.
• The immediate vesting of the granted shares provides immediate ownership to the director, reinforcing their stake in the company's performance.

Negatives

• No specific negative financial or operational information is disclosed in this Form 4 filing, as it pertains solely to an insider transaction.

Risks

• This Form 4 filing does not disclose specific risks related to the company's operations, financial health, or broader market conditions.

Future Outlook

This Form 4 filing details a specific insider transaction and does not provide forward-looking statements or guidance regarding the company's future performance or strategic outlook.

Management Comments

• The filing indicates that shares were granted under the Independent Directors' Equity Compensation Program, a component of the 2022 Equity and Incentive Plan, reflecting the company's established strategy for director remuneration and alignment of interests.

Industry Context

This Form 4 filing details an individual insider transaction (an equity grant to a director) and does not provide broader industry context or trends. Such grants are a common practice across various industries for compensating and incentivizing independent board members.

Management Changes

Corporate Governance

Legal Proceedings

• This Form 4 filing does not contain information regarding any legal proceedings or regulatory matters.

Related Party Transactions

• The transaction involves an equity grant to Marie J. McCarthy, an independent director of Camden National Corp, which is a standard related-party compensation arrangement under the company's approved equity plan.

Stakeholder Impact

• Shareholders may view the increased director ownership positively as it aligns the director's financial interests with the company's performance and shareholder value creation.
• Employees are not directly impacted by this specific insider transaction, though the overall compensation structure for directors contributes to corporate governance.

Next Steps

• This Form 4 filing does not outline specific future actions, events, or milestones for the company beyond the reported transaction.

Key Dates

Recommendation

Keywords

Camden National Corp, CAC, Form 4, insider transaction, equity grant, director compensation, stock ownership, beneficial ownership, dividend reinvestment program